FeesSafety
Pluang+

Lakefront Biotherapeutics creates 150,000 new subscription rights for employees under a new plan

Company Fundamentals
18 Nov 2026, 23:01 WIB
GlobeNewsWire
View Source
Neutral
Lakefront Biotherapeutics creates 150,000 new subscription rights for employees under a new plan

Lakefront Biotherapeutics announced the creation of 150,000 subscription rights under a new plan approved by its Board on November 10, 2026. These rights allow current and future employees to subscribe to new shares, supporting employee compensation and engagement. The plan is part of the company's authorized capital framework, complementing existing subscription rights and shareholding arrangements. This move aims to incentivize staff while maintaining shareholder value as Lakefront advances its clinical-stage biotech pipeline.

Lakefront Biotherapeutics' new subscription right plan is presented here with a snapshot of the health sector on Pluang as of Nov 19, 2026 04:02 WIB: Out of 150 priced health-sector US stocks, 49 rose and 100 fell. Among notable movers, SYRE rose 8.10% to USD 101.41 with a typical hold time of 6 days, contrasting with ELV which fell 7.36% to USD 401.98 and a 12-day hold time. TWST traded at USD 113.50, up 8.05%, but saw a majority 69% sell order activity and a longer hold time of 28 days.

More News

Alpha Tau Medical reports positive trial results ahead of earnings on Nov 19, 2026.

Alpha Tau Medical reports positive trial results ahead of earnings on Nov 19, 2026.

Alpha Tau Medical is set to report earnings on November 19, 2026, with expected losses of $0.15 per share and revenue of $125,000. The company announced positive clinical trial results from its U.S. REGAIN trial for Alpha DaRT therapy in glioblastoma...

Company Fundamentals
Bullish
54 minutes ago
Nvidia shares fall 2.9% despite strong earnings and raised revenue forecast amid leadership and regulatory concerns.

Nvidia shares fall 2.9% despite strong earnings and raised revenue forecast amid leadership and regulatory concerns.

Nvidia's stock dropped 2.9% to $150.96 after initially rising on strong quarterly results and a raised revenue forecast for fiscal 2028, projecting 75% annual growth. However, investor concerns about leadership uncertainty, including calls for former...

Neutral
1 hour ago
B&G Foods raises full-year sales and EBITDA guidance on strong volume growth and debt reduction plans

B&G Foods raises full-year sales and EBITDA guidance on strong volume growth and debt reduction plans

B&G Foods increased its full-year net sales and adjusted EBITDA guidance following a 5% volume-driven sales growth in Q3 2026. The company is expanding beyond traditional retail into food service, clubs, and private labels to utilize factory capacity...

Company Fundamentals
Bullish
1 hour ago
CoreWeave shares drop 4.13% amid strong AI demand but investor worries over debt and financing costs.

CoreWeave shares drop 4.13% amid strong AI demand but investor worries over debt and financing costs.

CoreWeave's stock fell 4.13% despite strong AI demand and Nvidia's solid earnings, as investors focus on the company's heavy debt and financing challenges. The company reported 168% revenue growth and raised its 2026 revenue forecast to $13-$13.3 bil...

Bearish
1 hour ago
Performance Food Group posts 5.5% sales growth, targets $125M procurement savings by 2028

Performance Food Group posts 5.5% sales growth, targets $125M procurement savings by 2028

Performance Food Group reported a 5.5% net sales increase in fiscal Q1 2027, driven by growth in independent restaurant orders and expanding gross profit margins. The company aims to achieve $125 million in annual procurement savings by fiscal 2028 t...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App